Light Sedation (Phendimetrazine Tartrate)

Adult dose

Adults: Administer 35 mg of Phendimetrazine Tartrate orally 2 to 3 times daily 1 hour before meals. The minimum effective dose should be used and adjusted as needed for individual response. For some patients, an intake of 17.5 mg once daily may be appropriate. The total dose should not exceed 70 mg at a time or 3 times per day. This medication should be administered for a short duration (within 4 weeks). Within the initial 4 weeks, if satisfactory weight loss is achieved (minimum weight loss of 1.8 kg or other agreed-upon satisfactory weight loss by both the doctor and the patient), treatment may be continued.

This medicine should be used alone and for a short duration, as using it with other appetite suppressants may lead to serious heart problems. Long-term use of this medication may increase the risk of a serious lung disease known as pulmonary hypertension; if symptoms occur, use should be halted immediately and a medical evaluation should be sought. As it may be associated with heart valve disease, the heart condition should be assessed before and during treatment, and it is advisable not to use this medication for individuals with heart problems. It should not be administered to those with specific heart diseases, hypertension, hyperthyroidism, glaucoma, mental anxiety conditions, or a history of substance abuse, or those currently taking central nervous system stimulants. Children under 16 years of age or women who are pregnant or may become pregnant should also not use this medication. Diabetic patients need to be cautious, as insulin dosage adjustment may be required when using this medication. This medication can affect the central nervous system, so attention is necessary when driving or operating hazardous machinery. Overdose may cause serious symptoms such as anxiety, coma, seizures, abnormal blood pressure, so prescribed dosages must be strictly adhered to. Pregnant women should avoid this medication as safety has not been established, and caution is needed for those who are breastfeeding. There is a potential for dependence with this medication, so sudden discontinuation after prolonged high-dose use can lead to extreme fatigue and depression. It should be kept out of the reach of children, and this medication is classified as a controlled substance requiring strict management.

Serious side effects

Urticaria, peripheral edema, potential development of pulmonary hypertension (symptoms like exercise-induced dyspnea, angina, fainting, peripheral edema), acute overdose may lead to coma, tremors, reflexive hyperactivity, respiratory stimulation, confusion, hallucinations, aggression, panic attacks, seizures, coma, and death, severe mental disorders, and cardiovascular irregularities (arrhythmias, hypertension, hypotension, circulatory collapse), severe skin disease, schizophrenia-like mental disorders

Mild side effects

• Palpitations
• tachycardia
• elevated blood pressure
• over-stimulation effects
• anxiety
• dizziness
• insomnia
• tremors
• euphoria
• headache

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and ensure it can be used safely.

Appearance

White, round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle